X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (694) 694
Book Review (93) 93
Publication (83) 83
Book Chapter (7) 7
Dissertation (4) 4
Government Document (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (529) 529
index medicus (523) 523
female (465) 465
breast neoplasms - genetics (291) 291
adult (267) 267
middle aged (266) 266
oncology (264) 264
breast cancer (237) 237
ovarian neoplasms - genetics (223) 223
brca1 (215) 215
breast/ovarian cancer (197) 197
mutation (195) 195
ovarian cancer (190) 190
male (170) 170
genetics & heredity (167) 167
genetic testing (160) 160
aged (153) 153
genes, brca1 (153) 153
ovarian-cancer (151) 151
genetic predisposition to disease (147) 147
cancer (145) 145
women (138) 138
genetic aspects (136) 136
brca2 (129) 129
risk (123) 123
genes, brca2 (118) 118
breast-cancer (108) 108
risk factors (108) 108
genetic counseling (106) 106
hereditary breast (98) 98
brca1 protein - genetics (95) 95
breast-ovarian cancer (94) 94
susceptibility (91) 91
families (89) 89
research (84) 84
brca2 protein - genetics (79) 79
genetic screening (76) 76
genetics (73) 73
pedigree (73) 73
genes (72) 72
gene mutations (63) 63
human genetics (62) 62
surveys and questionnaires (61) 61
hereditary breast/ovarian cancer (59) 59
mutations (59) 59
health aspects (58) 58
prevalence (58) 58
breast (56) 56
breast neoplasms - epidemiology (56) 56
epidemiology (54) 54
medicine & public health (54) 54
population (54) 54
genetic testing - psychology (53) 53
germline mutations (52) 52
breast neoplasms - psychology (51) 51
aged, 80 and over (50) 50
risk assessment (50) 50
diagnosis (49) 49
family-history (49) 49
biomedicine (48) 48
decision-making (48) 48
family (48) 48
article (47) 47
dna mutational analysis (47) 47
public, environmental & occupational health (47) 47
health knowledge, attitudes, practice (46) 46
genetic research (45) 45
ovarian neoplasms - epidemiology (44) 44
skin and connective tissue diseases (44) 44
analysis (42) 42
gene (42) 42
adolescent (41) 41
attitudes (40) 40
breast neoplasms - diagnosis (40) 40
endocrine system diseases (40) 40
impact (40) 40
oncology, experimental (40) 40
ovarian neoplasms - psychology (40) 40
breast neoplasms - pathology (39) 39
identification (39) 39
young adult (39) 39
carriers (38) 38
neoplasms - genetics (38) 38
germ-line mutation (36) 36
breast-ovarian-cancer (35) 35
ethics (35) 35
heterozygote (35) 35
decision making (34) 34
brca1 protein (33) 33
mutation - genetics (33) 33
brca2 protein (32) 32
nonpolyposis colorectal-cancer (32) 32
founder mutations (31) 31
cancer research (30) 30
family health (30) 30
founder effect (30) 30
high-risk (30) 30
medicine, general & internal (30) 30
ovarian neoplasms - diagnosis (30) 30
polymerase chain reaction (30) 30
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (571) 571
Japanese (71) 71
Chinese (46) 46
French (7) 7
German (4) 4
Romanian (2) 2
Dutch (1) 1
Korean (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2012, Volume 134, Issue 1, pp. 353 - 362
In spite the close association of the triple-negative breast cancer immunophenotype with hereditary breast cancers and the BRCA1 pathway, there is a lack of... 
Oncology | Hereditary breast–ovarian cancer | BRCA1 | Genetic testing | Medicine & Public Health | Triple-negative breast cancer | Hereditary breast-ovarian cancer | POLY(ADP-RIBOSE) POLYMERASE | GENOMIC REARRANGEMENTS | PHENOTYPE | FOUNDER MUTATIONS | ESTROGEN-RECEPTOR | EPIRUBICIN | ONCOLOGY | RANDOMIZED PHASE-III | GERMLINE MUTATIONS | DENSE SEQUENTIAL CHEMOTHERAPY | YOUNG-WOMEN | Carcinoma, Ductal, Breast - genetics | Receptors, Estrogen - metabolism | Carcinoma, Ductal, Breast - epidemiology | Genetic Testing | Prevalence | Hereditary Breast and Ovarian Cancer Syndrome - diagnosis | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Carcinoma, Lobular - epidemiology | Hereditary Breast and Ovarian Cancer Syndrome - metabolism | Patient Selection | Receptors, Progesterone - metabolism | Young Adult | Carcinoma, Lobular - genetics | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Carcinoma, Ductal, Breast - metabolism | Hereditary Breast and Ovarian Cancer Syndrome - genetics | Carcinoma, Lobular - diagnosis | Carcinoma, Ductal, Breast - diagnosis | BRCA1 Protein - genetics | Heterozygote | Aged | Carcinoma, Lobular - metabolism | Hereditary Breast and Ovarian Cancer Syndrome - epidemiology | Mutation | BRCA mutations | Oncology, Experimental | Breast cancer | Research | Toy industry | Genetic screening | Prevalence studies (Epidemiology) | Ovarian cancer | Analysis | DNA | Genetic aspects | Diagnosis | Cancer | Index Medicus
Journal Article
Hereditary Cancer in Clinical Practice, ISSN 1731-2302, 08/2015, Volume 13, Issue 1, pp. 16 - 16
The association of germline mutations in the breast cancer susceptibility gene 1 (BRCA1) and the breast cancer susceptibility gene 2 (BRCA2) with the... 
Non-breast/ovarian cancers | BRCA1 | BRCA2 | Prostate cancer | Stomach cancer | Pancreatic cancer | RISKS | DNA-DAMAGE | OVARIAN-CANCER | PREVALENCE | CARRIERS | BREAST-CANCER | ONCOLOGY | FAMILIES | GERMLINE MUTATIONS | SUSCEPTIBILITY GENE | CELL-CYCLE | Oncology, Experimental | Genes | Disease susceptibility | Research | Epidemiology | Ovarian cancer | Gene mutations | Genetic research | Genetic aspects | Cancer
Journal Article
Cancer Control, ISSN 1073-2748, 10/2016, Volume 23, Issue 4, pp. 359 - 372
Journal Article
Journal Article
Hereditary Cancer in Clinical Practice, ISSN 1731-2302, 05/2017, Volume 15, Issue 1, pp. 7 - 7
Background: The analysis of relationships of BRCA alterations with cancer at sites other than breast/ovary may provide innovative information concerning BRCA... 
Breast/ovarian cancer | Hereditary/non hereditary branch | Cancer in other sites | Hereditary syndrome | MUTATION CARRIERS | RISK | OVARIAN-CANCER | CELL LUNG-CANCER | BREAST-CANCER | WOMEN | ONCOLOGY | COHORT | PARP INHIBITORS | Liver cancer | Lung | Lung cancer | Breast cancer | Larynx | Mutation | Health risk assessment | Age | Ovarian cancer | Kidney transplantation | Tumors
Journal Article
by Jakubowska, A and Rozkrut, D and Antoniou, A and Hamann, U and Scott, R. J and McGuffog, L and Healy, S and Sinilnikova, O. M and Rennert, G and Lejbkowicz, F and Flugelman, A and Anulis, I. L and Glendon, G and Ozcelik, H and Thomassen, M and Paligo, M and Aretini, P and Kantala, J and Aroer, B and Von Wachenfeldt, A and Liljegren, A and Loman, N and Herbst, K and Kristoffersson, U and Rosenquist, R and Karlsson, P and Stenmark-Askmalm, M and Melin, B and Nathanson, K. L and Domchek, S. M and Byrski, T and Huzarski, T and Gronwald, J and Menkiszak, J and Cybulski, C and Serrano, P and Osorio, A and Cajal, T. R and Tsitlaidou, M and Benítez, J and Gilbert, M and Rookus, M and Aalfs, C. M and Kluijt, I and Boessenkool-Pape, J. L and Meijers-Heijboer, H. E. J and Oosterwijk, J. C and van Asperen, C. J and Blok, M. J and Nelen, M. R and van den Ouweland, A. M. W and Seynaeve, C and van der Luijt, R. B and Devilee, P and Easton, D. F and Peock, S and Frost, D and Platte, R and Ellis, S. D and Fineberg, E and Evans, D. G and Lalloo, F and Eeles, R and Jacobs, C and Adlard, J and Davidson, R and Eccles, D and Cole, T and Cook, J and Godwin, A and Bove, B and Stoppa-Lyonnet, D and Caux-Moncoutier, V and Belotti, M and Tirapo, C and Mazoyer, S and Barjhoux, L and Boutry-Kryza, N and Pujol, P and Coupier, I and Peyrat, J.-P and Vennin, P and Muller, D and Fricker, J.-P and Venat-Bouvet, L and Johannsson, O. Th and Isaacs, C and Schmutzler, R and Wappenschmidt, B and Meindl, A and Arnold, N and Varon-Mateeva, R and Niederacher, D and Sutter, C and Deissler, H and Preisler-Adams, S and Simard, J and Soucy, P and Durocher, F and Chenevix-Trench, G and ... and KConFab and EMBRACE and GEMO Study Collaborators and CIMBA and SWE BRCA and HEBON and OCGN and CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer and SWE-BRCA and on behalf of CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer and Medicinska fakulteten and Institutionen för strålningsvetenskaper and